Filing Details

Accession Number:
0001587221-17-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-25 20:45:58
Reporting Period:
2017-05-24
Filing Date:
2017-05-25
Accepted Time:
2017-05-25 20:45:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1587221 Zosano Pharma Corp ZSAN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1213529 Peter John Walker C/o Zosano Pharma Corporation
34790 Ardentech Court
Fremont CA 94555
Interim Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-24 36,166 $1.34 169,344 No 4 P Direct
Common Stock Acquisiton 2017-05-25 37,550 $1.37 206,894 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.33 to $1.35, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.34 to $1.38, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.